BioNTech (BNTX) shares fell almost 3% in recent Monday trading after Leerink Partners downgraded the stock to market perform from outperform and adjusted its price target to $113 from $112.
Trading volume stood at nearly 726,000 shares, versus the daily average of 1.2 million.
Price: 110.35, Change: -3.40, Percent Change: -2.99